Revised terminal half‐life of nonacog alfa as derived from extended sampling data: A real‐world study involving 64 haemophilia B patients on nonacog alfa regular prophylaxis

Autor: Brigitte Tardy, Thierry Lambert, Pierre Chamouni, Aurélie Montmartin, Marc Trossaert, Ségolène Claeyssens, Claire Berger, Laurent Ardillon, Valérie Gay, Xavier Delavenne, Annie Harroche, Pierre Chelle

Publikováno v: Haemophilia. 28:542-547

Nonacog alfa, a standard half-life recombinant factor IX (FIX), is used as a prophylactic treatment in severe haemophilia B (SHB) patients. Its half-life determined in clinical studies involving a limited sampling (72 h) was shown to be rather short.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::95ab662c0787a5a1d252576cb05669f0
https://doi.org/10.1111/hae.14560

Prostate biopsy and prostate cancer management in patients with haemophilia: The experience of French Haemophilia Treatment Centres

Autor: Philippe Gautier, Benoit Guillet, Marianne Sigaud, Ségolène Claeyssens, Fabienne Genre Volot, Pierre Chamouni, Anne Lienahrt, Birgit Frotscher, Alexandra Fournel, Sabine Castet, Catherine Poumayou, Valérie Gay, Rodolphe Thuret, Bénédicte Wibaut, Christine Biron‐Andreani

Publikováno v: Haemophilia. 28:437-444

Data are limited on prostate cancer (PC) management in patients with haemophilia (PWH).To describe PC screening and diagnosis, treatment modalities and bleeding complications in a group of unselected PWH followed at French Haemophilia Treatment Centr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9709f5ed31a98eebeca8734b030f9757
https://doi.org/10.1111/hae.14507

Identification of new F8 deep intronic variations in patients with haemophilia A

Autor: Pierre-Simon Rohrlich, Pierre Boisseau, Mathilde Fretigny, Amy Dericquebourg, Yohann Jourdy, Christine Vinciguerra, Catherine Ternisien, Ségolène Claeyssens, Anne Lienhart, Claude Negrier

Publikováno v: Haemophilia. 26:847-854

Introduction With current molecular diagnosis, about 1 to 5% of haemophilia A (HA) patients remain genetically unresolved. In these cases, deep intronic variation or structural variation disrupting the F8 gene could be causal. Aim To identify the cau

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::77a7df579eca25e228a84bc7427aa57c
https://doi.org/10.1111/hae.14134

Antithrombotic therapy management in patients with inherited bleeding disorders and coronary artery disease: A single‐centre experience

Autor: Ségolène Claeyssens, M.L. Piel-Julian, Laurent Sailler, Marie-Françoise Thiercelin-Legrand, Sophie Voisin, Guillaume Moulis

Publikováno v: Haemophilia. 26

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70a50d937207e2fcea5d96186f6c154e
https://doi.org/10.1111/hae.13904

Compliance with Early Long-Term Prophylaxis Guidelines for Severe Hemophilia A

Autor: Paul Saultier, Yves Guillaume, Virginie Demiguel, Claire Berger, Annie Borel-Derlon, Ségolène Claeyssens, Annie Harroche, Caroline Oudot, Anne Rafowicz, Marc Trossaert, Bénédicte Wibaut, Christine Vinciguerra, Mohamed Boucekine, Karine Baumstarck, Sandrine Meunier, Thierry Calvez, Hervé Chambost, Achille Aouba, Faezeh Legrand, Chantal Rothschild, Marie-Françoise Torchet, Roseline d’Oiron, Thierry Lambert, Yves Laurian, Jennifer Biernat, Jenny Goudemand, Armelle Parquet, Véronique Tintillier, Anne Durin Assollant, Claude Négrier, Sabine Castet, Viviane Guérin, Yohann Huguenin, Marguerite Micheau, Anne Ryman, Hérve Chambost, Céline Falaise, Marie Françoise Thiercelin-Legrand, Marianne Fiks-Sigaud, Marc Fouassier, Edith Fressinaud, Sophie Voisin, Albert Faradji, Patrick Lutz, Marie Elisabeth Briquel, Birgit Frotscher, Béatrice Fimbel, Yves Gruel, Claude Guerois, Sandra Regina, Jean Baptiste Valentin, Christine Biron Andreani, Philippe Codine, Daniel Donadio, Robert Navarro, Paola Rospide, Jean-François Schved, Bénédicte Collet, Annie Borel Derlon, Philippe Gautier, Sophie Bayart, Ben⊚ıt Guillet, JeanneYvonne Borg, Cécile Dumesnil, Charline Normand, Pascale Schneider, Philippe Tron, Jean-Pierre Vannier, Fabienne Dutrillaux, Fabienne Volot, Piotr Gembara, Alain Marques-Verdier, Dalila Adjaoud, Claire Barro, Gilles Pernod, Ben⊚ıt Polack, Patricia Pouzol, Nadra Ounnoughene, Patricia Paugy, Valérie Robert, Natalie Stieltjes, Brigitte Bastenaire, Emmanuelle de Raucourt, Jocelyne Peynet, Valérie Li-Thiao-Te, Brigitte Pautard, Catherine Behar, Stéphanie Gorde, Martine Munzer, Valérie Gay, Elisabeth Benz Lemoine, Laurent Macchi, Lionel De Lumley, Solange Gaillard, Anne Deville, Fabrice Monpoux, Marie Anne Bertrand, Brigitte Pan-Petesch, Abel Hassoun, Brigitte Coatmelec, Philippe Beurrier, Michèle Damay, Philippe Moreau, Odile Pouille-Lievin, Caroline Schoepfer, Eliane Tarral, Monique Bianchin, Joël Nguyen, Olivier Pincemaille, Marie-Odile Peter

Publikováno v: The Journal of Pediatrics
The Journal of Pediatrics, 2021, 234, pp.212-219.e3. ⟨10.1016/j.jpeds.2021.02.071⟩

International audience; Objectives: To evaluate the applicability and compliance with guidelines for early initiation of long-term prophylaxis in infants with severe hemophilia A and to identify factors associated with guideline compliance.Study desi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a04ba22efe053930d53178ae033337db
https://doi.org/10.1016/j.jpeds.2021.02.071